Thomas L. Hubka

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA.

Almirall LLC manufactures and distributes pharmaceutical products. Its products include tablets, gel, ointment, lotion, and topical cream. The company was founded by Jay Gooding and Craig Ballaron in 2004 and is headquartered in Exton, PA.

ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA.

Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA.

Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million.

Dickinson & Co. is a private company that specializes in security dealing and underwriting. The company is based in Des Moines, IA.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

The Securities Investor Protection Corporation either acts as trustee or works with an independent court-appointed trustee in a missing asset case to recover funds. The statute that created SIPC provides that customers of a failed brokerage firm receive all non-negotiable securities that are already registered in their names or in the process of being registered. Recovered funds are used to replenish SIPC's reserve in the event that the reserve is tapped in the early stages of a liquidation proceeding.

Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

Financial Industry Regulatory Authority, Inc. engages in the provision of securities regulation, complementary compliance, and technology-based services. Its services include writing and enforcing rules governing the activities of securities firms with brokers, examining firms for compliance with those rules, fostering market transparency, and educating investors. The company was founded in 2007 and is headquartered in Washington, DC.

Mesa Verde Venture Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of drug discovery/tools, medical devices & diagnostics and healthcare information technology. It provides financing for early stage capital requirements with an investment size of $0.5 - $1.5 million per company.

The Nicholas Conor Institute Corp. is an American company that focuses on researching and developing cancer treatments for adolescents. The private company was founded by Martin Latterich and the CEO is Beth Baber.

Proteogenomics Research Institute for Systems Medicine is a non-profit biomedical research institute that focuses on developing innovative treatments for important human diseases, including cancer and pulmonary fibrosis. The non-profit company is based in San Diego, CA, in the historic village of La Jolla. The institute employs the principles of systems science to study the relationships between healthy and diseased tissue, with the goal of developing more effective and less toxic treatments to improve patient care and address important unmet medical needs. Scientists at the institute have pioneered an integrated proteomic and imaging discovery platform for the identification and validation of tissue-specific delivery targets to enable the rapid and specific penetration of therapeutic agents directly into diseased tissue, including select solid tumors.

Objective Capital Partners LLC is an investment banking and valuation company that specializes in providing tenacious investment banking services for middle-market companies. The private company is based in San Diego, CA. The company's services include sell-side M&A, valuation, buy-side M&A, capital raise, and strategic planning.

Talapo Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in The company is headquartered in, CA.

Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada.

California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019.

Paracrine, Inc. is a biotechnology company that is developing a device-based autologous multifactorial cell therapy platform to treat chronic conditions. The private company is based in San Diego, CA. The company's cell therapy platform has multiple mechanisms of action that can address the underlying pathology of several debilitating chronic diseases. Paracrine is currently advancing multiple late-stage ide clinical trials based on robust prior data. The CEO of the company is Christopher James Calhoun.

Maternal Newborn Health Innovations Corp. is a company based in Kinnelon, NJ. Gary M. Cohen has been the CEOs since incorporation. Maternal Newborn Health Innovations Corp. was founded by Gary M. Cohen.